Owlstone Medical Ltd.
https://www.owlstonemedical.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Owlstone Medical Ltd.
Owlstone Medical Secures Funding To Develop Its Breath Biopsy Technology
The oversubscribed $58m funding round will enable the company to further work on its first-in-class breath biopsy technology, which aims to provide a cheap and convenient screening tool for several diseases.
Deal Watch: Roche Links With SemaThera, Acquires GenMark Diagnostics
Tempest goes public via a reverse merger with Millendo. Takeda inks its ninth deal of 2021, a discovery pact with BridGene around its chemoproteomics technology.
Thermo Fisher Scientific Partners With Breath Biopsy Firm Owlstone Medical
Thermo Fisher Scientific has signed a collaboration with Cambridge, UK-based Owlstone Medical to identify novel biomarkers.
AstraZeneca Enlists Owlstone Medical To Identify Asthma And COPD Biomarkers
Owlstone Medical has signed another major collaboration agreement with a big pharma company to use its breath biopsy services. The Cambridge, UK company is partnering with AstraZeneca to to identify novel breath biomarkers for asthma and COPD.
Company Information
- Industry
- Biotechnology
- Research, Analytical Equipment & Supplies
- Services
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Other Names / Subsidiaries
-
- Owlstone Inc.